Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2022 Mar 9;88(7):e02010-21. doi: 10.1128/aem.02010-21

Considerations about the Geographic Distribution of Histoplasma Species

Maria Lucia Taylor a,, María del Rocío Reyes-Montes a, Daniel A Estrada-Bárcenas b, Rosely M Zancopé-Oliveira c, Gabriela Rodríguez-Arellanes a, José Antonio Ramírez a
Editor: Martha Vivesd
PMCID: PMC9004366  PMID: 35262368

ABSTRACT

Histoplasmosis is a mycotic infection principally affecting pulmonary tissue; sometimes, histoplasmosis can progress into a systemic disease. This infection involves immunocompetent and immunosuppressed human and other mammalian hosts, depending on particular circumstances. Histoplasmosis infection has been documented worldwide. The infection is acquired by inhaling infective mycelial propagules of the dimorphic fungus Histoplasma capsulatum. New reports of clinical cases of histoplasmosis in extreme latitudes could be related to human social adaptations and climate changes in the world, which are creating new favorable environments for this fungus and for bats, its major natural reservoirs and dispersers. Histoplasma has been isolated from most continents, and it is considered a complex of cryptic species, consisting of various groups of isolates that differ genetically and correlate with a particular geographic distribution. Based on updated studies, Histoplasma taxonomy is adjusting to new genetic data. Here, we have suggested that Histoplasma has at least 14 phylogenetic species distributed worldwide and new genotypes that could be under deliberation. Histoplasma’s geographic radiation began in South America millions of years ago when the continents were joined and the climate was favorable. For fungal spreading, the role of bats and some birds is crucial, although other natural factors could also participate.

KEYWORDS: Histoplasma spp., worldwide distribution, climate changes, bats, spreading, Histoplasma capsulatum

INTRODUCTION

Systemic mycosis histoplasmosis evolves primarily as a respiratory infection with pulmonary involvement, acquired by inhalation of infective propagules of its causative agent, the dimorphic fungus Histoplasma capsulatum (1). H. capsulatum must be considered a primary pathogen due to its ability to cause disease in immunocompetent hosts. Sometimes, this fungus can act as an opportunistic microorganism, occasionally causing severe infection in immunosuppressed individuals (1). It is important to highlight that H. capsulatum does not colonize the upper and lower respiratory tracts of the host and that its presence in host tissues is always indicative of an active or latent infection process, usually associated with tissue modification and damage. H. capsulatum does not fulfill the parameters necessary to be considered a colonizing and a commensal microorganism, according to the Casadevall and Pirofski (2) criteria. H. capsulatum does not belong to the normal microbiota of the respiratory tract, nor is the respiratory epithelium an appropriate site to make commensalism for this type of respiratory pathogen. In addition, this pathogen does not need a colonization stage to increase the amount of its infective propagules, as do certain colonizing microorganisms.

Histoplasmosis is not contagious, and airborne transmission by nasal secretions has never been reported. Overall, this fungal infection is autolimited by the innate immune response of the host. Sometimes, depending on the condition of host innate defenses, the adaptive immune response is required to provide adequate protection by avoiding the development of the infection and promoting fast elimination of the fungus (3). Under this circumstance, adaptive immunity can be useful for detecting immunological evidence of past infections through a delayed hypersensitive reaction (positive histoplasmin skin test). In most cases, depending on the size of the inhaled inoculum, the virulence and the phylogenetic species of the fungal strain (Histoplasma genotypes), and the immune conditions of the host exposed to fungal propagules, clinical manifestations can progress from mild to severe forms of the disease with or without granulomatous reaction, and they can even lead to a fatal outcome (4).

Histoplasmosis infection in humans and other mammals has been reported on all continents (1), with the exception of Antarctica. The disease is predominant in American and African regions (5), where the infection is considered endemic. In recent years, human histoplasmosis cases have increased in areas of nonendemicity, as reported by Patel et al. (6). The epidemic form of histoplasmosis, usually associated with outbreaks, is described mainly in Latin American countries, where there is a close relationship between high risks of infection and human occupational and tourist activities (7, 8).

In the past, histoplasmosis was reported in tropical and subtropical regions of the world between latitudes 45°N and 35°S; however, autochthonous outbreaks in extreme latitudes, such as 54°N in AB, Canada (9) and 38°S in Argentinian Patagonia (10), suggest the major spreading of H. capsulatum in the environment. An increased number of histoplasmosis outbreaks and their reports at extreme latitudes may be attributed to environmental changes in the fungal ecological niche, as well as to behavioral changes of its natural reservoirs and dispersers, which undoubtedly supports a wider geographical distribution of H. capsulatum. This phenomenon could be associated with climate change and human social modifications, perhaps in adjustment to new economic conditions, influencing Histoplasma distribution. With regard to the role of climate change in the geographic expansion of Histoplasma, Kasuga et al. (11, 12) suggested that since a million years ago, Histoplasma spread from cold to temperate regions. This is compatible with the optimal conditions for its survival in the environment (saprobic stage) and in infected wild hosts (parasitic stage).

Histoplasma capsulatum is an ascomycete with a haploid anamorph asexual stage and a temporary and diploid teleomorph sexual stage, known as Ajellomyces capsulatus. H. capsulatum displays thermally regulated dimorphism, although other conditions can stimulate its morphogenesis. This fungus does not require an infectious life cycle for its maintenance in nature (13). However, the nonvirulent mycelial infective morphotype, which is organized with hyphae and conidia, aerosolizes mainly small hyphal fragments and microconidia that may be easily inhaled by mammalian hosts, creating an infectious life cycle (see Fig. 1). The nonvirulent characteristic of the mycelial morphotype was elegantly demonstrated in the past by Medoff (14), using an inhibitor of the fungal dimorphic transition. To cause progressive infection and disease in the host, a morphotype transition from the nonvirulent (mycelium) to the virulent (yeast) morphotype of H. capsulatum is essential (15). Therefore, once in the host compartment or in special culture medium at 37°C, the fungus activates its thermodimorphic process and converts to the yeast morphotype, which displays a multiplicity of virulence factors, enabling successful infection and producing pulmonary or disseminated diseases. H. capsulatum yeast is a facultative intracellular parasite that can survive and replicate within macrophages and other phagocytes. The yeast morphotype has developed efficient strategies to circumvent the intracellular antimicrobial activities of host cells (16).

FIG 1.

FIG 1

Representation of the H. capsulatum life cycle according to natural and host environments. (Photographs of tissue samples are courtesy of A. Pérez-Torres, used with permission; photos of infective M-phase and wild hosts are from the archive of Maria Lucia Taylor’s research laboratory.)

CURRENT PHYLOGEOGRAPHY OF HISTOPLASMA SPECIES BASED ON GENETIC DIVERSITY ANALYSES

Among dimorphic fungi, the Histoplasma genus is presumed to be one of the most widely spread in the world. Studies conducted by Vincent et al. (17), Spitzer et al. (18), and Keath et al. (19) showed that H. capsulatum consists of various groups of isolates that differ genetically and correlate with particular geographic distributions. Six classes (genotypes) were described. First, according to Vincent et al. (17), the fungus was classified into the following three classes: classes 1 and 2 were formed by some strains from the United States, and class 3 grouped a limited number of H. capsulatum strains from Central (Panama) and South America (Colombia). Subsequently, Spitzer et al. (18) incorporated class 4 into this previous genotyping classification, considering an H. capsulatum isolated in the soil from Florida, USA. Then, Keath et al. (19) identified other two genotypes (classes 5 and 6). Class 5, with four subclasses, 5a to 5d, comprised isolates from AIDS patients from Puerto Rico and isolates from Panama. Class 6, described by Keath et al. (19), was recognized in a DNA sample obtained from an AIDS-histoplasmosis patient from Panama.

Nowadays, Histoplasma is considered a complex of cryptic species (11, 12, 2022). An innovative phylogeographic study of H. capsulatum developed by Kasuga et al. (12) recorded seven phylogenetic species: North American class 1 (NAm 1), North American class 2 (NAm 2), Latin American group A (LAm A), Latin American group B (LAm B), Australian, Netherlands, and African clades. Due to low support values in phylogenetic reconstruction analyses, an 8th H. capsulatum clade, the Eurasian clade, had not been considered a phylogenetic species by Kasuga et al. (12), and to date, its precise classification remains uncertain.

Originally, based on its geographic distribution and clinical manifestations, H. capsulatum was classified into the following three varieties: H. capsulatum var. capsulatum, which is extensively distributed, H. capsulatum var. duboisii, found in Africa, and H. capsulatum var. farciminosum, reported mainly in Asia as a horse pathogen. Fungal isolates from this preliminary classification were reclassified into different phylogenetic species in the pioneering proposal of Kasuga et al. (12), changing the outdated original classification. Thus, H. capsulatum var. capsulatum was placed in all phylogenetic species, H. capsulatum var. duboisii belongs to African phylogenetic species, and H. capsulatum var. farciminosum is found in NAm 2, African phylogenetic species, and, particularly, the Eurasian clade.

Kasuga’s classification incorporates precise concepts that are very important for the taxonomy of Histoplasma, and this classification has been used to identify this fungus until now and to implement new taxonomic studies. Additional information has improved this classification, and according to Teixeira et al. (20), H. capsulatum has increased to 11 the number of phylogenetic species distributed worldwide (Australian, African, Netherlands, LAm A1, LAm A2, LAm B1, LAm B2, NAm 1, NAm 2, Rio de Janeiro named RJ, and a bat-associated species-specific clade denominated BAC1). A subsequent report (22) proposed replacing the BAC1 clade described by Teixeira et al. (20) by the NAm 3 phylogenetic species, which is a sister group of the NAm 2 clade. This proposal is sustained by six new isolates of H. capsulatum cultured from infected tissues of different migratory Tadarida brasiliensis (Chiroptera: Molossidae) bats.

Overall, the appearance of new genotypes in existing organisms is probably due to different selective pressures, forcing them to rapidly adapt to several changes in environmental conditions (23, 24). In addition, the advent of more robust and accurate approaches has allowed for easier detection of subtle changes in the fungal genome.

The presence of new genotypes in the Histoplasma complex has been documented in some Brazilian geographic regions (25, 26). Damasceno et al. (25) suggested the existence of two cryptic species of H. capsulatum in the northeastern region of Brazil (Ceará state), which have been named populations Northeast BR1 and BR2. Subsequently, Rodrigues et al. (26) described a new phylogenetic species called LAm C, emphasizing the low genetic diversity of this particular H. capsulatum population found in the Ceará state of Brazil. Thus, it is reasonable to speculate that the fungal populations described by Damasceno et al. (25) and Rodrigues et al. (26) from the Brazilian northeastern region share similar H. capsulatum genotypes by their respective fungal isolates. Rodrigues et al. (26) also proposed new lineages and two other groups with high genetic diversity (LAm D and LAm E) in southeastern Brazil.

According to the above-mentioned authors, at present, it is possible to consider 11 clades of Histoplasma distributed in the Americas, highlighting the most genetically diverse in Latin American countries (see Fig. 2).

FIG 2.

FIG 2

Distribution of the H. capsulatum genotypes on the American continent based on their current phylogeographic findings. Data were obtained from Kasuga et al. (12), Teixeira et al. (20), Damasceno et al. (25), Rodrigues et al. (26), and Vite-Garín et al. (22) classifications.

Instead, based on information about H. capsulatum cryptic speciation, Sepúlveda et al. (21) suggested other improvements to H. capsulatum classification using a robust phylogenomic methodology. These authors renamed four geographical clusters from the American continent previously identified by Kasuga et al. (12), describing them as species of the Histoplasma genus: H. capsulatum sensu stricto Darling 1906 from Panama (previously lineage H81), Histoplasma mississippiense sp. nov. (known as NAm 1) and Histoplasma ohiense sp. nov. (known as NAm 2) from the United States, and Histoplasma suramericanum sp. nov. (known as LAm A) considering some isolates from Colombia. Recently, Almeida-Silva et al. (27) analyzed the phylogenomic and population structure data of clinical and environmental Histoplasma isolates from Brazil and suggested that H. suramericanum has at least two populations in South America. They highlighted the southern population of H. suramericanum supported by fungal isolates from the phylogenetic species RJ, which is endemic to Rio de Janeiro. Thus, these new records make it necessary to demand more extensive and accurate evidences to reach the most adequate taxonomy for Histoplasma and to better understand the ancestral history of this fungal genus.

Consistent with the information published by Kasuga et al. (12), Teixeira et al. (20), Rodrigues et al. (26), and Vite-Garín et al. (22), which shared similarities in the phylogenetic reconstruction results of H. capsulatum, we assumed that this fungus has at least 14 phylogenetic groups (Table 1) and four lone lineages (Table 2), which undoubtedly supports the high diversity of the Histoplasma genus around the world.

TABLE 1.

Similarity of the H. capsulatum phylogenetic groups according to different reports

Phylogenetic species Number of isolatesa analyzed per phylogenetic species in reference:
Kasuga et al. (12) Teixeira et al. (20) Rodrigues et al. (26) Vite-Garín et al. (22)
NAm 1 4 12 17 4
NAm 2 16 22 74 16
NAm 3 1 (EH-315) 3 (BAC1) 4 (Group II) 7 (Nam 3)
LAm A1 NC 30 NC 9
a

The total number of H. capsulatum isolates analyzed through phylogenetic reconstruction per researcher group is indicated as follows: 137 by Kasuga et al. (12), 234 by Teixeira et al. (20), 474 by Rodrigues et al. (26), and 176 by Vite-Garín et al. (22). Isolates information was retrieved from different databases. NC, not considered.

TABLE 2.

H. capsulatum lone lineages that are in agreement with different reportsa

Lineages Number of isolatesa analyzed per phylogenetic species in reference:
Kasuga et al. (12) Teixeira et al. (20) Rodrigues et al. (26) Vite-Garín et al. (22)
H81/H82/H83 3 3 (Panama) 3 3
H140 2 2 (H140) 3 (140) 2
H153 1 1 1 2 (153/EH-696P)
H167 1 1 1 1
a

Additional lone lineages have also been proposed by the authors mentioned above.

AN OVERVIEW OF HISTOPLASMOSIS AND THE SPREADING OF HISTOPLASMA IN THE WORLD

Based on clinical cases and histoplasmin skin test reports, histoplasmosis is found to be distributed more extensively throughout the world than we previously thought. Epidemiological evidence of this mycosis, obtained from autochthonous clinical cases, has been found in Asia, Africa, Australia, and North, Central, and South America (1, 28). The presence of H. capsulatum in Europe was initially associated with imported clinical cases in tourists and immigrants with or without immunosuppression conditions. However, positive histoplasmin skin tests reported in human populations in Italy (1, 29), the description of fungal infections in the different tissues of two badgers (30) and a hedgehog (31) in northern Germany, and evidence of the fungal presence in an infected bat captured in France (32) all support the existence of new ecological niches with favorable environments for H. capsulatum growth and spread in Europe.

Histoplasma capsulatum has been isolated from naturally infected wild or captive animals, human patients, or its ecological niches worldwide (12, 3336). Kasuga et al. (12) studied fungal isolates from different sources, including human clinical cases, collected in 25 countries from five continents, confirming the important natural distribution of this pathogen.

In recent years, with the advent of molecular tools, the presence of H. capsulatum in humans and wild hosts has revealed a possible fungal spreading process over distant geographical regions. As already stated, the presence of H. capsulatum in the environment from France was demonstrated by González-González et al. (32), who studied samples from bats captured in two different regions of this country. They analyzed lung DNA samples from several bat specimens, using nested PCR amplification of the H. capsulatum Hcp100-specific marker; they found Hcp100-amplification in only one sample from a Nyctalus noctula (Chiroptera: Vespertilionidae) bat. The neighbor-joining analysis of the Hcp100 sequence obtained from the lung DNA of N. noctula revealed a high similarity with the sequence of the G217B H. capsulatum strain from Louisiana, USA. Different migratory routes of N. noctula have been reported in Northern, Central, and Eastern Europe (37), increasing the likelihood that N. noctula has acquired the fungus from other regions during its migration, in accordance with its role in fungal spreading in new environments. Recently, da Silva et al. (38), using the same molecular approach, investigated natural infection by H. capsulatum in bats from the Amazonian Forest region that have suffered climate and anthropogenic disturbances. They also studied bats captured in urban areas from Pará state in Brazil, which also belongs to the Amazonian region. They found two infected frugivorous bats, Carollia perspicillata and Vampyriscus bidens (Chiroptera: Phyllostomidae), out of 100 bats captured. Because Pará constantly suffers environmental disturbances resulting from deforestation for land use, it is possible to hypothesize that these disturbances may create conditions favoring H. capsulatum infection in susceptible human and mammalian hosts. Surprisingly, in both papers reported here, the infection rate in wild bats was very low, possibly explained by the recent infection events associated with fungal spreading in these areas that are only now suffering modifications in their fungal natural habitats. It is important to highlight that although the infection rate in these flying mammal hosts is occasionally low, their role as H. capsulatum dispersers is more important than the role of terrestrial mammal hosts since bats are able to cross long distances. This ability of bats is one of the probable reasons that H. capsulatum is so widespread, in contrast to other systemic pathogenic fungi, such as Coccidioides spp. and Paracoccidioides spp., whose dispersion is associated mainly with terrestrial mammal reservoirs and whose evolutionary history with bats is probably very recent, which agrees with the scarce reports of these fungal isolations in bats (39, 40).

The spread of Histoplasma over several countries on different continents could have occurred a long time ago, involving natural alterations or environmental changes related to human and other mammalian behaviors. According to Kasuga et al. (12), Histoplasma began its geographic radiation mainly in South America 3.2 to 13 million years ago, in the Pliocene and Miocene, when the continents were already merged and the global climate was warmer than it is today. Hence, as a result of this radiation, some clades have remained unlimited, such as LAm A in South America, which is widely distributed and the most genetically diverse. This high diversity could be due to fungal sexual reproduction events in the environment, which are responsible for the recombining population structures reported for this clade. Other clades were delimited into template geographic areas, where the fungal population presented less genetic diversity, probably due to asexual reproduction, generating clonal population structures, as in the case of LAm B and NAm 1 Histoplasma clades.

According to Rodrigues et al. (26), the high genetic diversity found in several isolates from Brazil, together with the presence of divergent cryptic species, suggests the role of bat and bird species in fungal spreading around the Brazilian territory and that this country could be the epicenter of Histoplasma dispersion in South America, which agrees with the Histoplasma geographic radiation proposed by Kasuga et al. (12).

In addition to the role of bats, other natural environmental factors, such as winds, tropical torments (storms, hurricanes), and, interestingly, the airstreams in bat caves, could contribute to spreading out airborne fungal mycelial spores. Birds are undoubtedly another natural disperser of fungal spores, causing fungal dispersion mainly over short distances, but birds are not considered genuine reservoirs of H. capsulatum. To date, there are only random data confirming bird infection with H. capsulatum, such as the report by Quist et al. (41) of a coinfection with histoplasmosis and candidiasis in an Eclectus roratus parrot (Psittaciformes: Psittaculidae). It is well known that H. capsulatum grows favorably in soil containing guano from several species of bat and avian (mainly hens, chickens, and other birds), which have a high content of micronutrients. In different countries, guano from hens, chickens, or bats is manufactured as organic fertilizer, which is associated with a high risk of infection by Histoplasma aerosolized infective propagules (4244).

Considering that birds move around in this contaminated soil, the fungus could be dispersed by air through their feathers over their surroundings and other diverse environments. Among the birds more frequently associated with H. capsulatum dispersion, we usually found starlings and black birds. Curiously, in Central and South America, Steatornis caripensis (Caprimulgiformes: Steatornithidae), called oilbirds or “guácharos,” which is known to be a cave-dwelling bird, is also related to fungal dispersion. Another factor that could be involved in the spreading of H. capsulatum is the fungal interactions with different organisms of the microbiota that belong to bat guano and share the same ecological niche, such as the biological association between the fungus and mites present in bat guano (45). Mites consume organic components and microorganisms of the bat guano as part of their food web. Based on the findings reported by Estrada-Bárcenas et al. (45), Sancassania sphaerogaster (Acari: Acaridae) mites collected from the same microhabitat of H. capsulatum were able to eat H. capsulatum growing under laboratory conditions. In addition to this mycophagous activity, S. sphaerogaster mites also showed fungal phoresy when they were in contact with H. capsulatum cultures, suggesting that a short-range dispersion of the fungus may occur under natural conditions (45).

THE HISTORY BETWEEN BATS AND H. CAPSULATUM: THEIR RELATIONSHIP WITH THE GLOBAL GEOGRAPHICAL CHANGES

Since Kunz (33) compiled bat species, from which the fungus was isolated between 1970 and 1981, there has been an increasing number of bat species from which H. capsulatum has been isolated, particularly in America.

Bats are geographically dispersed and act as natural hosts for many pathogens, including fungi. Climate changes can influence the geographic distribution and abundance of bat species. Accelerated urbanization, deforestation, and invasion of their natural habitats have increased the risk of zoonotic diseases (46).

Infected bats are considered the main reservoir and disperser of H. capsulatum, which grows in their guano, which is rich in nitrogen, phosphorous, and other micronutrient contents (4749). In most cases, the fungus is returned to environments through the carcasses, urine, and feces of infected bats, thus renewing the fungal load of other bat shelters (see Fig. 1). The role of bat feces in fungal dispersion is dubious because negative fungal isolation in repetitive assays was always found in bat fecal samples collected through the intestinal lavage of 208 bats analyzed, although H. capsulatum isolates were indeed recovered by culture of intestine tissue samples from seven bats. Histopathologic studies revealed a few alterations in the mucous membrane of the intestine without any inflammatory reactions (40). Likewise, no evidence of severe inflammatory reactions in the liver and spleen tissue sections of several bats was observed. However, cultures of H. capsulatum were obtained from these organs, which suggested the presence of dissemination processes in these infected specimens (47). However, according to Tesh and Schneidau (50), H. capsulatum was cultured from the fecal samples of experimentally infected T. brasiliensis bats, and the existence of yeasts in the kidneys of the infected bats suggests that bats and other mammal hosts could eliminate the fungus in their urine.

The size of bat populations may be related to anthropogenic activities, but the course of bats’ symptomatic diseases must be considered another factor responsible for the decrease in their population. A significant percentage of T. brasiliensis bats captured in either Mexico or Argentina were infected with H. capsulatum, as demonstrated by González-González et al. (51). Certainly, a high population density of T. brasiliensis in their shelters increases the risk of infection, resulting in an increased percentage of H. capsulatum infections in their colonies. The physical conditions of bat shelters could also increase the risk of infection for humans and bats, as has been documented by Taylor et al. (47). Thus, the colonial behavior of cave-dwelling bats and their high fidelity to the shelters along their migratory route, in the case of migratory bats, are important factors for explaining the dynamics of H. capsulatum dispersion in nature.

The interplay between H. capsulatum and bats could involve modifications in the physiology of wild hosts and their self-protective mechanisms against this type of microorganism. Possibly both geographic and climate changes, producing different selective pressures, have influenced the interactions between distinct organisms that share the same ecological niche, consequently giving them a common evolutionary history. The interaction between H. capsulatum and bats may have occurred since the Late Pliocene, considering the dated fossil of Tadarida sp. reported by Morgan and Ridgway (52). In particular, the interaction between H. capsulatum and T. brasiliensis could have taken place in the Late Pleistocene, in agreement with the first fossil report of this bat species by Morgan (53).

In addition, the finding reported by Taylor et al. (54), regarding the presence of a unique GACG(GA)11GA haplotype of the (GA)n microsatellite in a highly specific cluster formed by nine H. capsulatum isolates cultured from T. brasiliensis tissue samples, advocates for a probable parallel evolution between T. brasiliensis and H. capsulatum. It is also interesting to mention that until now, the NAm 3 phylogenetic species of H. capsulatum, previously mentioned in this paper, and the fungal GACG(GA)11GA haplotype have been associated with only naturally infected T. brasiliensis bats in Mexico. The latter suggests that these flying mammals are susceptible to particular genotypes of H. capsulatum and that this million-year-long host-parasite interaction has possibly evolved into a species-specific relationship.

NEW GENOTYPES OF HISTOPLASMA AND THEIR IMPACT IN THE HISTOPLASMOSIS CLINICAL MANIFESTATIONS

It has been difficult to determine how fungal genotypes impact histoplasmosis clinical course and manifestations. It will be suitable to accept that differences in virulence factors among H. capsulatum strains from different genotypes are the unique responsible cause. However, in the interplay between the fungus and the host, several host-associated factors could interfere with the outcome of histoplasmosis infection, such as sex, age, stress, nutritional conditions, risk of massive infective inoculum (depending on occupational and tourist activities), immunosuppression, and genetic predisposition to certain clinical manifestations of histoplasmosis (7, 8).

Regarding H. capsulatum genotypes versus clinical manifestations of histoplasmosis, data have been accumulated over time in distant geographical areas. The NAm 1 phylogenetic species has been isolated primarily from AIDS patients, in contrast to NAm 2 phylogenetic species, which can infect immunocompetent and immunosuppressive hosts (11). Clinical differences between AIDS-associated histoplasmosis patients from Brazil and those from the United States, in regard to H. capsulatum strains isolated from Latin America and North America, have been documented (55, 56), highlighting an increased dermatotropism in the Latin American H. capsulatum genotypes, which causes frequent skin and mucocutaneous clinical manifestations.

Interesting published data (25, 57) have recorded some compelling clinical cases of coinfection with different genotypes of H. capsulatum (Northeast BR1 and BR2) in the same AIDS-histoplasmosis patient, which also revealed differences in their mating types (MAT1-1 and MAT1-2). Although the consequences of this type of coinfection are unknown at present, it is possible to assume that this coinfection could interfere with the host immune response and pathogenesis of the disease.

At the experimental level, differences in the outcome of the disease and in the host tissue damage caused by distinct H. capsulatum genotypes were first reported by Durkin et al. (58), who infected mice intratracheally with sublethal doses of yeasts from Latin America (classes 5 and 6) and North America (class 2) fungal strains. They found that class 5 and 6 strains caused more tissue damage and fatal outcomes in mice than class 2 H. capsulatum strain.

Sepúlveda et al. (59), using Histoplasma strains representative of the NAm 1 and NAm 2 phylogenetic species as well as those from the Panama lineage to infect mice intranasally with low or high sublethal doses of H. capsulatum yeasts, showed that clinical manifestations (weight loss), pathogenesis (lung inflammatory infiltrate), host response (cytokines production), and disease resolution (fungal clearance) differed in these experimental histoplasmosis models, depending on the H. capsulatum inoculum size and the virulence of its phylogenetic group. Their results highlight the highest virulence of the lineage from Panama in mice exposed to a lower yeast inoculum, rather than NAm 1 and NAm 2 strains. Later, Jones et al. (60), studying the same conditions to generate murine histoplasmosis infection, suggested that yeasts of the NAm 2 strain of Histoplasma are found mostly within alveolar macrophages and produce progressive lung inflammation, contrasting with the Histoplasma lineage from Panama.

Finally, an original contribution by Sahaza et al. (4), using susceptible mice intranasally infected with mycelial infective propagules, showed clear differences in cytokines production during the course of murine histoplasmosis when two distinct H. capsulatum genotypes were used, underscoring how an LAm A strain from Mexico induced higher levels of pro- and anti-inflammatory cytokines in the lungs of infected mice than an NAm 2 strain from the United States.

CONCLUSIONS

Climate change can lead to H. capsulatum genotype selection so the fungus can adapt better to new environments. The geographical expansion of histoplasmosis can be attributed to environmental factors, be it “natural” or occasioned by humans. Natural factors are associated mainly with bird or bat involvement. Bats are considered the most significant dispersers for H. capsulatum worldwide. Dispersal through the air is another mechanism whereby this pathogen can be spread, usually over short geographical distances.

ACKNOWLEDGMENTS

Considerations and partial data for this work were compiled by the biomedical research team of MLT, which was supported by grant IN213515 from the “Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica-Dirección General de Asuntos del Personal Académico” from UNAM- Mexico. R.M.Z.O. was supported in part by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 302796/2017-7) and Fundação Carlos Chagas Filho de Amparo á Pesquisa do Estado do Rio de Janeiro (FAPERJ E-26/202.527/2019) from Brazil.

Contributor Information

Maria Lucia Taylor, Email: emello@unam.mx.

Martha Vives, Unversidad de los Andes.

REFERENCES

  • 1.Bahr NC, Antinori S, Wheat LJ, Sarosi GA. 2015. Histoplasmosis infections worldwide: thinking outside of the Ohio River valley. Curr Trop Med Rep 2:70–80. 10.1007/s40475-015-0044-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Casadevall A, Pirofski L. 2000. Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Infect Immun 68:6511–6518. 10.1128/IAI.68.12.6511-6518.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mittal J, Ponce MG, Gendlina I, Nosanchuk JD. 2019. Histoplasma capsulatum: mechanisms for pathogenesis. Curr Top Microbiol Immunol 422:157–191. 10.1007/82_2018_114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sahaza JH, Suárez-Alvarez R, Estrada-Bárcenas DA, Pérez-Torres A, Taylor ML. 2015. Profile of cytokines in the lungs of BALB/c mice after intra-nasal infection with Histoplasma capsulatum mycelial propagules. Comp Immunol Microbiol Infect Dis 41:1–9. 10.1016/j.cimid.2015.05.003. [DOI] [PubMed] [Google Scholar]
  • 5.Ferreira MS, Borges AS. 2009. Histoplasmosis. Rev Soc Bras Med Trop 42:192–198. 10.1590/s0037-86822009000200020. [DOI] [PubMed] [Google Scholar]
  • 6.Patel AK, Patel KK, Toshniwal H, Gohel S, Chakrabarti A. 2018. Histoplasmosis in non-endemic North-Western part of India. Indian J Med Microbiol 36:61–64. 10.4103/ijmm.IJMM_18_12. [DOI] [PubMed] [Google Scholar]
  • 7.Taylor ML, Granados J, Toriello C. 1996. Biological and sociocultural approaches of histoplasmosis in the State of Guerrero, Mexico. Mycoses 39:375–379. 10.1111/j.1439-0507.1996.tb00157.x. [DOI] [PubMed] [Google Scholar]
  • 8.Taylor ML, Pérez-Mejía A, Yamamoto-Furusho JK, Granados J. 1997. Immunologic, genetic and social human risk factors associated to histoplasmosis: studies in the State of Guerrero, Mexico Mycopathologia 138:137–142. 10.1023/a:1006847630347. [DOI] [PubMed] [Google Scholar]
  • 9.Anderson H, Honish L, Taylor G, Johnson M, Tovstiuk C, Fanning A, Tyrrell G, Rennie R, Jaipaul J, Sand C, Probert S. 2006. Histoplasmosis cluster, golf course, Canada. Emerg Infect Dis 12:163–165. 10.3201/eid1201.051083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Calanni LM, Pérez RA, Brasili S, Schmidt NG, Iovannitti CA, Zuiani MF, Negroni R, Finquelievich J, Canteros CE. 2013. Outbreak of histoplasmosis in province of Neuquén, Patagonia Argentina. Rev Iberoam Micol 30:193–199. 10.1016/j.riam.2012.12.007. [DOI] [PubMed] [Google Scholar]
  • 11.Kasuga T, Taylor JW, White TJ. 1999. Phylogenetic relationships of varieties and geographical groups of the human pathogenic fungus Histoplasma capsulatum Darling. J Clin Microbiol 37:653–666. 10.1128/JCM.37.3.653-663.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kasuga T, White TJ, Koenig G, McEwen J, Restrepo A, Castañeda E, Da Silva Lacaz C, Heins-Vaccari EM, De Freitas RS, Zancopé-Oliveira RM, Qin Z, Negroni R, Carter DA, Mikami Y, Tamura M, Taylor ML, Miller GF, Poonwan N, Taylor JW. 2003. Phylogeography of the fungal pathogen Histoplasma capsulatum. Mol Ecol 12:3383–3401. 10.1046/j.1365-294x.2003.01995.x. [DOI] [PubMed] [Google Scholar]
  • 13.Denham ST, Wambaugh MA, Brown JCS. 2019. How environmental fungi cause a range of clinical outcomes in susceptible hosts. J Mol Biol 431:2982–3009. 10.1016/j.jmb.2019.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Medoff G, Sacco M, Maresca B, Schlessinger D, Painter A, Kobayashi GS, Carratu L. 1986. Irreversible block of the mycelial-to-yeast phase transition of Histoplasma capsulatum. Science 231:476–479. 10.1126/science.3001938. [DOI] [PubMed] [Google Scholar]
  • 15.Medoff G, Kobayashi GS, Painter A, Travis S. 1987. Morphogenesis and pathogenicity of Histoplasma capsulatum. Infect Immun 55:1355–1358. 10.1128/iai.55.6.1355-1358.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ray SC, Rappleye CA. 2019. Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition. Semin Cell Dev Biol 89:91–98. 10.1016/j.semcdb.2018.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Vincent RD, Goewert R, Goldman WE, Kobayashi GS, Lambowitz AM, Medoff G. 1986. Classification of Histoplasma capsulatum isolates by restriction fragment polymorphisms. J Bacteriol 165:813–818. 10.1128/jb.165.3.813-818.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Spitzer ED, Lasker BA, Travis SJ, Kobayashi GS, Medoff G. 1989. Use of mitochondrial and ribosomal DNA polymorphisms to classify clinical and soil isolates of Histoplasma capsulatum. Infect Immun 57:1409–1412. 10.1128/iai.57.5.1409-1412.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Keath EJ, Kobayashi GS, Medoff G. 1992. Typing of Histoplasma capsulatum by restriction fragment length polymorphisms in a nuclear gene. J Clin Microbiol 30:2104–2107. 10.1128/jcm.30.8.2104-2107.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Teixeira MdM, Patané JSL, Taylor ML, Gómez BL, Theodoro RC, de Hoog S, Engelthaler DM, Zancopé-Oliveira RM, Felipe MSS, Barker BM. 2016. Worldwide phylogenetic distributions and population dynamics of the genus Histoplasma. PLoS Negl Trop Dis 10:e0004732. 10.1371/journal.pntd.0004732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Sepúlveda VE, Márquez R, Turissini DA, Goldman WE, Matute DR. 2017. Genome sequences reveal cryptic speciation in the human pathogen Histoplasma capsulatum. mBio 8:e01339-17. 10.1128/mBio.01339-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Vite-Garín T, Estrada-Bárcenas DA, Gernandt DS, Reyes-Montes MR, Sahaza JH, Canteros CE, Ramírez JA, Rodríguez-Arellanes G, Serra-Damasceno L, Zancopé-Oliveira RM, Taylor JW, Taylor ML. 2021. Histoplasma capsulatum isolated from Tadarida brasiliensis bats captured in Mexico form a sister group to North American class 2 clade. JoF 7:529. 10.3390/jof7070529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Gienapp P, Teplitsky C, Alho JS, Mills JA, Merilä J. 2008. Climate change and evolution: disentangling environmental and genetic responses. Mol Ecol 17:167–178. 10.1111/j.1365-294X.2007.03413.x. [DOI] [PubMed] [Google Scholar]
  • 24.Hoffmann AA, Sgrò CM. 2011. Climate change and evolutionary adaptation. Nature 470:479–485. 10.1038/nature09670. [DOI] [PubMed] [Google Scholar]
  • 25.Damasceno LS, Teixeira MM, Barker BM, Almeida MA, Muniz MM, Pizzini CV, Lima Mesquita JR, Rodríguez-Arellanes G, Ramírez JA, Vite-Garín T, Silva Leitão TMJ, Taylor ML, Almeida-Paes R, Zancopé-Oliveira RM. 2019. Novel clinical and dual infection by Histoplasma capsulatum genotypes in HIV patients from Northeastern, Brazil. Sci Rep 9:11789. 10.1038/s41598-019-48111-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Rodrigues AM, Beale MA, Hagen F, Fisher MC, Terra PPD, de Hoog S, Brilhante RSN, de Aguiar Cordeiro R, de Souza Collares Maia Castelo-Branco D, Rocha MFG, Sidrim JJC, de Camargo ZP. 2020. The global epidemiology of emerging Histoplasma species in recent years. Stud Mycol 97:100095.001. 10.1016/j.simyco.2020.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Almeida-Silva F, Teixeira MM, Matute DR, Faria Ferreira M, Barker BM, Almeida-Paes R, Guimarães AJ, Zancopé-Oliveira RM. 2021. Genomic diversity analysis reveals a strong population structure in Histoplasma capsulatum LAmA (Histoplasma suramericanum). J Fungi 7:865. 10.3390/jof7100865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Antinori S. 2014. Histoplasma capsulatum: more widespread than previously thought. Am J Trop Med Hyg 90:982–983. 10.4269/ajtmh.14-0175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mochi A, Edwards PQ. 1952. Geographical distribution of histoplasmosis and histoplasmin sensitivity. Bull World Health Organ 5:259–291. [PMC free article] [PubMed] [Google Scholar]
  • 30.Wohlsein P, Bauder B, Kuttin ES, Kaufman L, Seeliger F, von Keyserlingk M. 2001. Histoplasmosis in two badgers (Meles meles) in northern Germany. Dtsch Tierarztl Wochenschr 108:273–276. [PubMed] [Google Scholar]
  • 31.Jacobsen B, Baumgärtner W, Bialek R. 2011. Disseminated histoplasmosis in a European hedgehog (Erinaceus europaeus) in Northern Germany. Mycoses 54:538–541. 10.1111/j.1439-0507.2010.01886.x. [DOI] [PubMed] [Google Scholar]
  • 32.González-González AE, Ramírez JA, Aliouat-Denis CM, Demanche C, Aliouat EM, Dei-Cas E, Chabé M, Taylor ML. 2013. Molecular detection of Histoplasma capsulatum in the lung of a free-ranging common noctule (Nyctalus noctula) from France using the Hcp100 gene. J Zoo Wildl Med 44:15–20. 10.1638/1042-7260-44.1.15. [DOI] [PubMed] [Google Scholar]
  • 33.Kunz TH. 1988. Ecological and behavioral methods for the study of bats. Smithsonian Institution Press, Washington, DC. [Google Scholar]
  • 34.Chávez-Tapia CB, Vargas-Yañez R, Rodríguez-Arellanes G, Peña-Sandoval GR, Flores-Estrada JJ, Reyes-Montes MR, Taylor ML. 1998. I. El murciélago como reservorio y responsable de la dispersión de Histoplasma capsulatum en la naturaleza. II. Papel de los marcadores moleculares del hongo aislado de murciélagos infectados. Rev Inst Nal Enf Resp Mex 11:187–191. [Google Scholar]
  • 35.Vargas-Yañez R, Peña-Sandoval GR, Chávez-Tapia CB, Taylor ML. 1998. Infección natural por Histoplasma capsulatum en animales silvestres. Rev Inst Nal Enf Resp Mex 11:192–194. [Google Scholar]
  • 36.Rosas-Rosas A, Juan-Sallés C, Rodríguez-Arellanes G, Taylor ML, Garner MM. 2004. Disseminated Histoplasma capsulatum var. capsulatum infection in a captive mara (Dolichotis patagonum). Vet Rec 155:426–428. 10.1136/vr.155.14.426. [DOI] [PubMed] [Google Scholar]
  • 37.Petit E, Mayer F. 2000. A population genetic analysis of migration: the case of the noctule bat (Nyctalus noctula). Mol Ecol 9:683–690. 10.1046/j.1365-294x.2000.00896.x. [DOI] [PubMed] [Google Scholar]
  • 38.da Silva JA, Scofield A, Barros FN, de Farias DM, Riet-Correa G, Bezerra Júnior PS, Santos TFS, Tavares GSF, Trevelin LC, da Paz GS, Cerqueira VD. 2021. Molecular detection of Histoplasma capsulatum in bats of the Amazon biome in Pará state, Brazil. Transbound Emerg Dis 68:758–766. 10.1111/tbed.13740. [DOI] [PubMed] [Google Scholar]
  • 39.Cordeiro RA, Silva KRC, Brilhante RSN, Moura FBP, Duarte NFH, Marques FJF, Cordeiro RA, Moreira Filho RE, de Araújo RWB, Bandeira TJPG, Rocha MFG, Sidrim JJC. 2012. Coccidioides posadasii infection in bats. Emerg Infect Dis 18:668–670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.da Paz GS, Adorno BMV, Richini-Pereira VB, Bosco SMG, Langoni H. 2018. Infection by Histoplasma capsulatum, Cryptococcus spp. and Paracoccidioides brasiliensis in bats collected in urban areas. Transbound Emerg Dis 65:1797–1805. 10.1111/tbed.12955. [DOI] [PubMed] [Google Scholar]
  • 41.Quist EM, Belcher C, Levine G, Johnson M, Heatley JJ, Kiupel M, Giri D. 2011. Disseminated histoplasmosis with concurrent oral candidiasis in an Eclectus parrot (Eclectus roratus). Avian Pathol 40:207–211. 10.1080/03079457.2011.554796. [DOI] [PubMed] [Google Scholar]
  • 42.Gómez LF, Torres IP, Jiménez-A MP, McEwen JG, De Bedout C, Peláez CA, Acevedo JM, Taylor ML, Arango M. 2018. Detection of Histoplasma capsulatum in organic fertilizers by hc100 nested polymerase chain reaction and its correlation with the physicochemical and microbiological characteristics of the samples. Am J Trop Med Hyg 98:1303–1312. 10.4269/ajtmh.17-0214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Gómez LF, Arango M, McEwen JG, Gómez OM, Zuluaga A, Peláez CA, Acevedo JM, Taylor ML, Jiménez MP. 2019. Molecular epidemiology of Colombian Histoplasma capsulatum isolates obtained from human and chicken manure samples. Heliyon 5:e02084. 10.1016/j.heliyon.2019.e02084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gómez Londoño LF, Pérez León LC, McEwen Ochoa JG, Zuluaga Rodriguez A, Peláez Jaramillo CA, Acevedo Ruiz JM, Taylor ML, Arango Arteaga M, Jiménez Alzate MP. 2019. Capacity of Histoplasma capsulatum to survive the composting process. Appl Environ Soil Sci 2019:1–9. 10.1155/2019/5038153. [DOI] [Google Scholar]
  • 45.Estrada-Bárcenas DA, Palacios-Vargas JG, Estrada-Venegas E, Klimov PB, Martínez-Mena A, Taylor ML. 2010. Biological activity of the mite Sancassania sp. (Acari: Acaridae) from bat guano associated with the pathogenic fungus Histoplasma capsulatum. Mem Inst Oswaldo Cruz 105:127–131. 10.1590/s0074-02762010000200003. [DOI] [PubMed] [Google Scholar]
  • 46.Wells K, Clark NJ. 2019. Host specificity in variable environments. Trends Parasitol 35:452–465. 10.1016/j.pt.2019.04.001. [DOI] [PubMed] [Google Scholar]
  • 47.Taylor ML, Chávez-Tapia CB, Vargas-Yañez R, Rodríguez-Arellanes G, Peña-Sandoval GR, Toriello C, Pérez A, Reyes-Montes MR. 1999. Environmental conditions favoring bat infection with Histoplasma capsulatum in Mexican shelters. Am J Trop Med Hyg 61:914–919. 10.4269/ajtmh.1999.61.914. [DOI] [PubMed] [Google Scholar]
  • 48.Veloso SCS, Ferreiro L, Pacheco SM, Da Silva RRP, de Conceição Souza E, Machado G, Sanches EMC. 2014. Pneumocystis spp. e Histoplasma capsulatum detectados em pulmões de morcegos das regiões Sul e Centro-Oeste do Brasil. Acta Sci Vet 42:1–7. [Google Scholar]
  • 49.dos Santos B, Langoni H, da Silva RC, Menozzi BD, Bosco SMG, Paiz LM, Augusto LCR, Richini-Pereira VB. 2018. Molecular detection of Histoplasma capsulatum in insectivorous and frugivorous bats in Southeastern Brazil. Med Mycol 56:937–940. 10.1093/mmy/myx138. [DOI] [PubMed] [Google Scholar]
  • 50.Tesh RB, Schneidau JD. 1966. Experimental infection of North American insectivorous bats (Tadarida brasiliensis) with Histoplasma capsulatum. Am J Trop Med Hyg 15:544–550. 10.4269/ajtmh.1966.15.544. [DOI] [PubMed] [Google Scholar]
  • 51.González-González AE, Aliouat-Denis CM, Ramírez-Bárcenas JA, Demanche C, Pottier M, Carreto-Binaghi LE, Akbar H, Derouiche S, Chabé M, Aliouat EM, Dei-Cas E, Taylor ML. 2014. Histoplasma capsulatum and Pneumocystis spp. co-infection in wild bats from Argentina, French Guyana, and Mexico. BMC Microbiol 14:23. 10.1186/1471-2180-14-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Morgan GS, Ridgway RB. 1987. Late Pliocene (late Blancan) vertebrates from the St. Petersburg Times site, Pinellas County, Florida, with a brief review of Florida Blancan faunas. Florida Paleontology 1:1–22. [Google Scholar]
  • 53.Morgan GS. 1985. Fossil bats (Mammalia: Chiroptera) from the late Pleistocene and Holocene Vero fauna, Indian River County, Florida. Brimleyana 11:97–117. [Google Scholar]
  • 54.Taylor ML, Hernández-García L, Estrada-Bárcenas D, Salas-Lizana R, Zancopé-Oliveira RM, García De La Cruz S, Galvão-Dias MA, Curiel-Quesada E, Canteros CE, Bojórquez-Torres G, Bogard-Fuentes CA, Zamora-Tehozol E. 2012. Genetic diversity of Histoplasma capsulatum isolated from infected bats randomly captured in Mexico, Brazil and Argentina, using the polymorphism of (GA)n microsatellite and its flanking regions. Fungal Biol 116:308–317. 10.1016/j.funbio.2011.12.004. [DOI] [PubMed] [Google Scholar]
  • 55.Karimi KL, Wheat J, Connolly P, Cloud G, Hajjeh R, Wheat E, Alves K, da Silva Lacaz C, Keath E. 2002. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 186:1655–1660. 10.1086/345724. [DOI] [PubMed] [Google Scholar]
  • 56.Goldani LZ, Aquino VR, Lunardi LW, Cunha VS, Santos RP. 2009. Two specific strains of Histoplasma capsulatum causing mucocutaneous manifestations of histoplasmosis: preliminary analysis of a frequent manifestation of histoplasmosis in southern Brazil. Mycopathologia 167:181–186. 10.1007/s11046-008-9171-7. [DOI] [PubMed] [Google Scholar]
  • 57.Serra Damasceno L, Vite-Garín T, Ramírez JA, Rodríguez-Arellanes G, Abreu de Almeida M, de Medeiros Muniz M, Lima de Mesquita JR, Silva Leitão TMJ, Taylor ML, Zancopé-Oliveira RM. 2019. Mixed infection by Histoplasma capsulatum isolates with different mating types in Brazilian AIDS-patients. Rev Inst Med Trop Sao Paulo 61:e8. 10.1590/S1678-9946201961008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Durkin MM, Connolly PA, Karimi K, Wheat E, Schnizlein-Bick C, Allen SD, Alves K, Tewari RP, Keath E. 2004. Pathogenic differences between North American and Latin American strains of Histoplasma capsulatum var. capsulatum in experimentally infected mice. J Clin Microbiol 42:4370–4373. 10.1128/JCM.42.9.4370-4373.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Sepúlveda VE, Williams CL, Goldman WE. 2014. Comparison of phylogenetically distinct Histoplasma strains reveals evolutionarily divergent virulence strategies. mBio 5:e01376-14. 10.1128/mBio.01376-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Jones GS, Sepúlveda VE, Goldman WE. 2020. Biodiverse Histoplasma species elicit distinct patterns of pulmonary inflammation following sublethal infection. mSphere 5:e00742-20. 10.1128/mSphere.00742-20. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES